Skip to main content
. 2021 Oct 4;2021:5513868. doi: 10.1155/2021/5513868

Table 1.

Selected treatments investigated in clinical trials for COVID-19..

Antiviral Anti-inflammatory Anticoagulation and antivasculopathy
Arbidol Acalabrutinib Argatroban
Azithromycin (antibiotic) Anakinra Alteplase
Camostat mesilate (reduce viral infection) Aviptadil Alteplase
Chloroquine or hydroxychloroquine Baricitinib (janus kinase (JAK) inhibitor) Acetylsalicylic acid
Clevudine Chlorpromazine Atorvastatin (HMG-CoA inhibitor)
Darunavir/Cobicistat (Prezcobix; Rezolsta) Colchicine Bevacizumab (antivascular endothelial growth factors (VEGF))
Favipiravir (Avigan®) Deferoxamine Clopidogrel
Interferon Dexamethasone Crizanlizumab (vasculopathy)
Ivermectin plus nitazoxanide Dornase alfa (Pulmozyme®) Dapagliflozin (sodium-glucose transporter-2 inhibitor)
Lactoferrin Duvelisib Enoxaparin
Lopinavir-ritonavir (Kaletra®) Eculizumab Fondaparinux
Nafamostat (blocks TMPRSS2 activation and SARS-CoV-2 cell entry) Famotidine Heparin
Oseltamivir Hydrocortisone Losartan (angiotensin II receptor blocker (ARB))
Remdesivir Imatinib Nitric oxide (inhalation)
Nicotine
Umifenovir Infliximab Ramipril (angiotensin-converting enzyme inhibitor (ACEi))
Isotretinoin Rivaroxaban (direct oral anticoagulant (DOAC))
Leflunomide Sulodexide
Methylprednisolone
Morphine
Telmisartan (ARB)
Ozanimod Valsartan (ARB)
Plitidepsin
Prednisolone
Ruxolitinib (JAK inhibitor)
Sarilumab
Sirolimus
Tocilizumab (IL-6 inhibitor)
Tofacitinib (JAK inhibitor)
Antioxidant treatment Traditional Chinese medicine Oxygen therapy
Vitamin A Single herbs Oxygen inhalation
Vitamin C Chinese patent formulas Mechanical ventilation
Vitamin D Chinese herbal compounds Prone position ventilation
Vitamin E Hyperbaric oxygen therapy
Glutathione Oxyhydrogen inhalation via a nebulizer
N-Acetyl-L-cysteine (NAC)
Melatonin
Zinc
Vaccine and antibodies Extracorporeal membrane oxygenation support
mRNA, recombinant protein, vector Oxygenation, removal of CO2, filtrating proinflammatory cytokines via a filter
Pamrevlumab
Anti-SARS-CoV-2 convalescent plasma

Selected from 9149 total COVID-19 studies, including 6115 from COVID-19 NIH registered clinical trials [5] and the rest registered outside of the USA found from WHO International Clinical Trials Registry Platform (ICTRP) database [68].